PhD Opportunity: The use of Health Technology Assessment in publicly funded health systems

/0 Comments/in , /by
The Faculty of Health at Dalhousie University is inviting applications to consider entry into Dalhousie’s PhD Health program. This is an exciting opportunity to work with Dr. W. Dominika Wranik in the area of Health Technology Assessment, with particular focus on the application of HTA to policy questions in publicly (more…)

Watch Now: Social Determinants of Health and Cancer

/0 Comments/in /by
Check out the excellent presentation below by Ambreen Sayani – Health Policy & Equity PhD Student and ARCC member since 2016. Any questions can be directed by Ambreen at asayani1@yorku.ca .  This presentation was made at the Drug Pricing Policy Summit 2018 and the video was made and hosted by the Save (more…)

Research Participation Wanted – Patients & Survivors of Colorectal Cancer

/0 Comments/in , /by
Please help ARCC Researcher Mary de Vera understand the information needs of patients and survivors of colorectal cancer if possible! Dr. Mary de Vera of the University of British Columbia is taking on the cancer she herself was treated for – read more about her story in the Globe and (more…)
The Canadian Centre for Applied Research in Cancer Control

Announcing the 2019 ARCC Studentship Winners!

/0 Comments/in /by
We are pleased to announce the results of the  2019 ARCC Studentship Competition. Successful Applications The 2019 ARCC Studentship Competition resulted in the approval of 5 awards, with 2 Master’s level recipients, and 3 Doctoral level recipients. ARCC Received a total of 25 submissions for an overall success rate of (more…)
The Canadian Centre for Applied Research in Cancer Control

ARCC 2019 Abstract Submission NOW OPEN!

/0 Comments/in /by
We are pleased to announce that abstract submission for the 2018 ARCC Conference is NOW OPEN! We encourage you to submit your work and join us in Halifax, May 27-28, 2019. Registration will open in mid-January 2019. Visit our conference webpage at  https://cc-arcc.ca/arcc-conference-2019/ for the most up-to-date conference information including (more…)

CONNECT Study is recruiting patients and survivors of colorectal cancer

/0 Comments/in , /by
Share Your Voice! We are helping promote a research study conducted at the University of British Columbia by Dr. Mary De Vera, who is a survivor of colorectal cancer. Mary was awarded an ARCC Seed Grant in support of this work, and we are happy to see the project is (more…)

Call for Nominations – Chair of the Ontario Cancer Research Ethics Board

/0 Comments/in , /by
The Ontario Cancer Research Ethics Board (OCREB) Advisory Committee, on behalf of the Board of Directors of the Ontario Institute for Cancer Research (OICR), is calling for nominations for the Chair of OCREB. The position is part-time (up to two days per week) and would take effect September 1, 2019. (more…)

CPAC – Help Modernize Canada’s Cancer Plan

/0 Comments/in /by
We need a bit of your time. Help modernize Canada’s cancer plan with #30MinutesThat Matter. The Canadian Partnership Against Cancer is asking Canadians to share their experiences with cancer to directly shape how prevention, screening, care and survivorship programs are delivered in this country over the next decade, and we (more…)

Webinar – Health Economics for Non-Economists, Friday Oct. 26th @ 1:00pm EST

/0 Comments/in , /by
ARCC Methods Webinar – Add this meeting to your Calendar (iCal) Topic of presentation Health Economics for Non-Economists Date & Time Friday October 26, 2018 1:00pm – 2:00pm (EST) 10:00am – 11:00pm (PST) 2:00pm – 3:00pm (AT) Presenters Ms. Jaclyn Beca, Manager – Pharmacoeconomics Research Unit, Cancer Care Ontario Mr. (more…)

Drug Pricing Policy Summit – Travel Awards Available for ARCC members

/0 Comments/in , , /by
Click here for Travel Award Application BioCanRx HQP, Network Investigator and ARCC Travel Award RE: Drug Pricing Policy Summit, Toronto, November 13-14, 2018 Summary The BioCanRx mission is to build and foster a network that accelerates Canada’s most promising biologically based cancer therapies into clinical trials. Canadian scientists and students (more…)